SPG20 Antikörper (AA 1-350)
-
- Target Alle SPG20 Antikörper anzeigen
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Bindungsspezifität
- AA 1-350
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPG20 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- SPG20 Rabbit pAb
- Sequenz
- MEQEPQNGEP AEIKIIREAY KKAFLFVNKG LNTDELGQKE EAKNYYKQGI GHLLRGISIS SKESEHTGPG WESARQMQQK MKETLQNVRT RLEILEKGLA TSLQNDLQEV PKLYPEFPPK DMCEKLPEPQ SFSSAPQHAE VNGNTSTPSA GAVAAPASLS LPSQSCPAEA PPAYTPQAAE GHYTVSYGTD SGEFSSVGEE FYRNHSQPPP LETLGLDADE LILIPNGVQI FFVNPAGEVS APSYPGYLRI VRFLDNSLDT VLNRPPGFLQ VCDWLYPLVP DRSPVLKCTA GAYMFPDTML QAAGCFVGVV LSSELPEDDR ELFEDLLRQM SDLRLQANWN RAEEENEFQI
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-350 of human SPG20 (NP_055902.1).
- Isotyp
- IgG
- Top Product
- Discover our top product SPG20 Primärantikörper
-
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 18-45), (N-Term) antibody
SPG20 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB22531 unconjugated
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 24-54), (N-Term) antibodySPG20 Reaktivität: Human WB, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 431-480) antibodySPG20 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Meerschweinchen, Pferd, Kaninchen, Fledermaus, Hamster, Affe, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Middle Region) antibodySPG20 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB,1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Andere Bezeichnung
- SPG20 (SPG20 Produkte)
- Hintergrund
- This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008],SPARTIN,TAHCCP1,SPG20,spartin,SPG20
- Molekulargewicht
- 72kDa
- Gen-ID
- 23111
- UniProt
- Q8N0X7
- Pathways
- Regulation of Cell Size, SARS-CoV-2 Protein Interaktom
-
